Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/22/2025

Hypertension Management

Initial Treatment

  • For African Americans with hypertension, the American College of Cardiology recommends a thiazide diuretic or calcium channel blocker (CCB) as the first-line medication choice due to superior efficacy in this population compared to other antihypertensive classes 1
  • African Americans have a greater blood pressure-lowering response to thiazide diuretics and CCBs compared to other antihypertensive classes 1

Combination Therapy

  • For Stage 2 hypertension (≥140/90 mmHg), the American Heart Association recommends beginning with combination therapy using a thiazide diuretic plus CCB 2
  • Most African American patients will require ≥2 antihypertensive medications to achieve adequate blood pressure control, with a preferred combination of thiazide diuretic + CCB 1
  • The European Society of Cardiology and the American Heart Association suggest that for most patients with confirmed hypertension, combination therapy is recommended as initial treatment, with preferred combinations including RAS blocker + dihydropyridine CCB or RAS blocker + thiazide-type diuretic, and fixed-dose single-pill combinations to improve adherence 3, 4, 5, 2

Medication Dosage and Selection

  • Thiazide diuretics should be administered at 12.5-25 mg/day for chlorthalidone or 25-50 mg/day for hydrochlorothiazide for optimal efficacy 1
  • The American College of Cardiology recommends including a thiazide diuretic plus beta-blocker in the treatment regimen 1
  • The American College of Cardiology and the American Heart Association recommend the following medications for specific patient populations:
Medication Recommended Use
Thiazide-type diuretic First-line kidney protective medication for diabetic African-American males with hypertension, and for patients with heart failure
Calcium channel blocker (CCB) First-line kidney protective medication for diabetic African-American males with hypertension
ACE inhibitors Important components of multidrug regimens for African American dialysis patients, especially when proteinuria is present
Angiotensin receptor blockers (ARBs) Preferred over ACE inhibitors in black patients due to a lower risk of angioedema
Beta-blockers Recommended for patients with concomitant coronary artery disease, post-MI, or heart failure

Lifestyle Modifications

  • The European Society of Cardiology and the American Heart Association recommend at least 150 minutes of moderate-intensity aerobic activity per week, with 2-3 sessions of resistance training weekly, and a minimum of 30 minutes on most days, for patients with hypertension 3, 6, 7, 8, 9
  • The American Diabetes Association and the American Heart Association suggest implementing the DASH diet, focusing on fruits, vegetables, low-fat dairy, whole grains, and reduced saturated fat, with a target sodium intake of <2,300 mg/day, for patients with hypertension, particularly African Americans who often have greater salt sensitivity 10, 8, 9
  • Weight loss of 10 kg is associated with a 6.0/4.6 mmHg BP reduction in overweight/obese patients, and alcohol moderation, with ≤2 drinks/day for men and ≤1 drink/day for women, is recommended for patients with hypertension 6, 7

Special Considerations

  • African Americans have a greater risk of angioedema with ACE inhibitors 1
  • For diabetic nephropathy, an ARB or ACE inhibitor is recommended, while without nephropathy, a thiazide diuretic or CCB remains first-line 1
  • The American Diabetes Association suggests that ARBs may be preferable to ACE inhibitors in women of childbearing potential due to teratogenic risks of ACE inhibitors 10
  • For patients with chronic kidney disease (CKD), an ACE inhibitor or ARB (preferably ARB due to lower risk of angioedema in African Americans) should be added to the treatment regimen, with a target blood pressure of <140/90 mmHg, and losartan may help manage hyperuricemia in patients with this condition 1, 11, 3
  • For patients with heart failure, a thiazide diuretic plus beta-blocker should be included in the treatment regimen, and for patients with post-MI or coronary heart disease, a beta-blocker should be added to the treatment regimen 1

Monitoring and Follow-up

  • The European Society of Cardiology and the American College of Cardiology recommend checking serum electrolytes and renal function within 1 month of starting therapy, especially with ACE inhibitors, ARBs, or diuretics, and regular monitoring of blood pressure within 2-4 weeks of initiation and aiming to achieve target blood pressure within 3 months 10, 11, 4, 1
  • The American College of Cardiology and the American Heart Association recommend targeting a blood pressure of <130/80 mmHg, with consideration of increasing to a three-drug combination if blood pressure is not controlled on initial therapy, and patients starting antihypertensive therapy should be monitored for side effects 4, 11, 1

REFERENCES